CBD and recovery — the evidence base

TL;DR

• Preclinical: CBD lowers cytokines (TNF-α, IL-6).
• Small RCTs in athletes: trends, no robust DOMS effect.
• Best evidence: subjective sleep & anxiety — both recovery-relevant.
• Doses in studies: 25 – 300 mg/day orally.

Realistic expectations?

McCartney 2020 summarises: evidence for CBD as a DOMS 'wonder-drug' is weak. Realistic upside: better sleep, less competition anxiety, moderate drop in subjective muscle tension. Hard endpoints (creatine-kinase clearance, post-eccentric strength loss) show no clear effect yet.

Physiological mechanisms and the role of the endocannabinoid system

The endocannabinoid system plays an essential role in maintaining physiological balance after intense physical exertion. During training, fine microtraumas occur in the muscles, triggering natural inflammatory processes in the tissue. Cannabidiol interacts indirectly with the body's own CB1 and CB2 receptors and also influences various non-cannabinoid receptors. These interactions can theoretically help support the body's own regulation during oxidative stress and muscular strain, without completely blocking the body's natural adaptation mechanisms.

Beyond direct receptor binding, the active ingredient influences the breakdown of endogenous cannabinoids such as anandamide. By inhibiting certain enzymes, the concentration of these endogenous neurotransmitters can increase, which in turn can contribute to relaxation and subjective well-being. In contrast to classic non-steroidal anti-inflammatory drugs, which often completely suppress the inflammatory signals necessary for muscle building, a modulating approach is being researched for this natural substance. This could help athletes make the recovery phase more efficient, while the training-induced adaptation processes of the muscles remain largely preserved.

• Modulation of the endocannabinoid system to support physiological homeostasis after sports.
• Interaction with receptors that are partly responsible for regulating pain signals and inflammation.
• Increase in the body's own anandamide levels through the targeted inhibition of enzymatic degradation.
• Potentially modulating influence on inflammatory processes compared to classic anti-inflammatory drugs.

Swiss legal framework and relevance for sports

For athletes in Switzerland, the legal framework is of central importance when selecting recovery products. Products with a total THC content of less than 1 % are legally permitted and do not fall under the Narcotics Act. Nevertheless, competitive athletes in particular must be extremely precise when selecting products. Although pure cannabidiol is no longer banned by WADA, other cannabinoids such as THC remain prohibited in competition. Traces of THC in insufficiently purified full-spectrum products can therefore lead to unexpected problems during doping controls.

Another critical point is the strict Swiss road traffic legislation. A strict zero-tolerance policy applies here, with a legal limit of 1.5 µg/L of THC in blood. Anyone who regularly or in high doses consumes products that fully exploit the permitted THC limit of less than 1 % risks accumulation in the body. In the context of traffic checks, this can lead to a positive test result and the revocation of the driving licence. Swiss athletes should therefore preferably rely on certified, completely THC-free isolates.

• Free sale in Switzerland only with a total THC content of less than 1 %.
• WADA guidelines allow pure cannabidiol, but prohibit THC in a competitive context.
• Risk of positive doping tests due to incompletely purified full-spectrum preparations.
• Strict Swiss limit of 1.5 micrograms of THC per litre of blood in road traffic.

Dosage forms and application practices in daily training

In athletic practice, various dosage forms have established themselves, which differ significantly in their bioavailability and the speed of onset of action. Sublingual oils are absorbed directly through the oral mucosa, whereby the active ingredient bypasses the gastrointestinal tract and is available in the system relatively quickly. This is particularly advantageous when timely support for relaxation before sleep is desired. Capsules, on the other hand, must first pass through the liver, which leads to a delayed but often more even and longer-lasting release.

For the targeted treatment of specific muscle groups, topical applications such as creams, gels, or ointments are ideal. These penetrate locally into the upper layers of the skin and act directly on the receptors there, without entering the bloodstream in significant quantities. This minimises the risk of systemic side effects or unwanted detection during controls. Regardless of the chosen form, athletes should always rely on products with independent Swiss laboratory analyses to ensure the exact composition and freedom from contaminants.

• Sublingual administration for rapid absorption, bypassing the first-pass effect.
• Oral capsules for a delayed but long-lasting delivery of the active ingredient.
• Topical creams for targeted care and local application on stressed muscles.
• Necessity of independent laboratory certificates to verify the exact ingredients.

FAQ